Study of two experimental drugs for high blood pressure and cholesterol
Part of Heart & circulation clinical trials.
This trial tests whether taking two experimental drugs together can safely lower both high blood pressure and high cholesterol. It may be an option if you have both conditions and your blood pressure is not extremely high.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years of age or older.
- You have been diagnosed with high blood pressure (essential hypertension).
- You have been diagnosed with high cholesterol (primary hypercholesterolemia).
- Your blood pressure readings in both arms are not too different from each other (less than 20 points difference for the top number and less than 10 points for the bottom number).
- Your average blood pressure is not extremely high (top number below 180 and bottom number below 110).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how two investigational drugs interact when taken together in healthy adults. It looks at safety and how the drugs move through the body.
This study tests whether adding two medications together helps people who have both high blood pressure and high cholesterol. It aims to see if the combination works better and is safe.
This trial compares a lower-dose cholesterol pill (rosuvastatin plus ezetimibe) to a higher-dose version of just rosuvastatin for people with mild to moderate heart artery blockages who have not had a stent or bypass. It aims to see which approach works better and is safer.
This study tests whether a combination of two cholesterol-lowering medicines—a low-dose statin and ezetimibe—is safe and feasible for people with very early signs of artery hardening but no major blockages. It aims to see if this treatment can help prevent heart problems from getting worse.
This trial compares a high-dose combination of rosuvastatin (a statin) and ezetimibe (another cholesterol-lowering drug) versus a standard rosuvastatin-only approach for people with peripheral artery disease (narrowed leg arteries) or widespread artery disease. The goal is to see which strategy better lowers LDL cholesterol and reduces heart and limb risks.
This trial tests a combination pill of two cholesterol-lowering medicines (pitavastatin and ezetimibe) in adults who have been taking either atorvastatin or rosuvastatin for at least 3 months. It aims to see if switching to this new combination is safe and effective.
Hear when a new High blood pressure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.